Jingwei Shi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Jingwei Shi has a total of 42 co-authors. Here are the top co-authors by number of shared publications:
He Zhao
Department of Laboratory Medicine Center, China-Japan Union Hospital of Jilin University, Changchun, China
4 shared publicationsWeiyao Zhong
Department of Laboratory Medicine Center, China-Japan Union Hospital of Jilin University, Changchun, China
3 shared publicationsPeilin Wang
Department of Analytical Chemistry, College of Chemistry, Jilin University, Changchun, 130012, China
2 shared publications- Qiang Ma
Jilin University
2 shared publications Zihui Liang
Department of Analytical Chemistry, College of Chemistry, Jilin University, Changchun, 130012, China
2 shared publicationsBingYue Sun
China-Japan Union Hospital, Jilin University, Changchun, Jilin Province, China
1 shared publication
Latest Publications
- Open Access
- 30 September 2025
- Published by Wiley in Advanced Science
- Vol. 12 (47) , e09309
Hyaluronic Acid Hydrogel Implants for Sustained Release of Oxaliplatin and Resiquimod to Prevent Hepatocellular Carcinoma Recurrence Post‐Radiofrequency Ablation
Hepatocellular carcinoma (HCC) remains a global challenge due to limited therapies and high recurrence. While radiofrequency ablation (RFA) is commonly used, its efficacy is hindered by incomplete ablation. Local immunotherapy has gained attention as a novel strategy to improve therapeutic efficacy through targeted activation of anti‐tumor immunity. In this work, a biopolymer implant (BI) hydrogel based on hyaluronic acid is developed for the sustained release of oxaliplatin (OXA) and resiquimod (R848), aiming to enhance the immunotherapeutic efficacy of RFA in liver cancer. The injectable BI hydrogel, formed via Schiff base linkage, enables prolonged drug release and exhibits favorable biosafety. In subcutaneous HCC models, RFA + BI(OXA + R848) achieved 97.1% tumor inhibition and 40% complete remission. Additionally, the combination therapy is further validated in bilateral tumor and orthotopic HCC models, demonstrating superior tumor suppression. Furthermore, flow cytometry and RNA sequencing confirmed that RFA combined with BI(OXA + R848) significantly enhanced intratumoral dendritic cell activation, promoted the recruitment of CD8⁺ T lymphocytes and NK cells, and induced robust immune memory. This synergistic engagement of the innate‐adaptive immune axis underscores its potential to address challenges in both local tumor control and systemic recurrence prevention.
- 30 September 2025
- Published by Wiley in Advanced Science
- Vol. 12 (47) , e09309
Open AccessHyaluronic Acid Hydrogel Implants for Sustained Release of Oxaliplatin and Resiquimod to Prevent Hepatocellular Carcinoma Recurrence Post‐Radiofrequency Ablation
Hepatocellular carcinoma (HCC) remains a global challenge due to limited therapies and high recurrence. While radiofrequency ablation (RFA) is commonly used, its efficacy is hindered by incomplete ablation. Local immunotherapy has gained attention as a novel strategy to improve therapeutic efficacy through targeted activation of anti‐tumor immunity. In this work, a biopolymer implant (BI) hydrogel based on hyaluronic acid is developed for the sustained release of oxaliplatin (OXA) and resiquimod (R848), aiming to enhance the immunotherapeutic efficacy of RFA in liver cancer. The injectable BI hydrogel, formed via Schiff base linkage, enables prolonged drug release and exhibits favorable biosafety. In subcutaneous HCC models, RFA + BI(OXA + R848) achieved 97.1% tumor inhibition and 40% complete remission. Additionally, the combination therapy is further validated in bilateral tumor and orthotopic HCC models, demonstrating superior tumor suppression. Furthermore, flow cytometry and RNA sequencing confirmed that RFA combined with BI(OXA + R848) significantly enhanced intratumoral dendritic cell activation, promoted the recruitment of CD8⁺ T lymphocytes and NK cells, and induced robust immune memory. This synergistic engagement of the innate‐adaptive immune axis underscores its potential to address challenges in both local tumor control and systemic recurrence prevention.
- Open Access
- 19 March 2025
- Published by Frontiers Media SA in Frontiers in Cellular and Infection Microbiology
- Vol. 15, 1556048
Association between hematological inflammatory markers and latent TB infection: insights from NHANES 2011–2012 and transcriptomic data
Background: Latent tuberculosis infection affects about one-quarter of the global population and can progress to active tuberculosis. Hematological inflammatory markers, such as the systemic immune-inflammation index, neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and monocyte-to-lymphocyte ratio, reflect systemic inflammation and immune status but are understudied in latent tuberculosis infection. This study investigates the association between these markers and latent tuberculosis infection in a nationally representative sample.Methods: Data from 7,042 participants in the 2011–2012 National Health and Nutrition Examination Survey and transcriptomic data from the GSE19491 dataset were analyzed. Latent tuberculosis infection was identified using the QuantiFERON-TB Gold assay. Hematological parameters were measured via complete blood counts, and inflammatory markers were calculated through these parameters. Statistical analyses included linear regression adjusted for confounders and subgroup analyses. Transcriptomic analyses involved immune cell profiling, gene set enrichment, and immune checkpoint gene expression.Results: Individuals with latent tuberculosis infection had significantly lower systemic immune-inflammation index, neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and monocyte-to-lymphocyte ratio. These associations remained significant after adjusting for age, gender, body mass index, diabetes, and hypertension. Transcriptomic analyses revealed heightened activation of memory CD4 and CD8 T cells, increased cytolytic activity, and upregulated T-cell co-inhibition pathways, alongside differential expression of immune checkpoint genes in individuals with latent tuberculosis infection.Conclusions: A lower systemic immune-inflammation index and other related hematological inflammatory markers independently correlate with latent tuberculosis infection. These findings underscore the potential significance of hematological inflammatory markers in identifying and understanding latent tuberculosis infection. Further exploration of these markers may enhance diagnostic and therapeutic strategies of tuberculosis.
- 19 March 2025
- Published by Frontiers Media SA in Frontiers in Cellular and Infection Microbiology
- Vol. 15, 1556048
Open AccessAssociation between hematological inflammatory markers and latent TB infection: insights from NHANES 2011–2012 and transcriptomic data
Background: Latent tuberculosis infection affects about one-quarter of the global population and can progress to active tuberculosis. Hematological inflammatory markers, such as the systemic immune-inflammation index, neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and monocyte-to-lymphocyte ratio, reflect systemic inflammation and immune status but are understudied in latent tuberculosis infection. This study investigates the association between these markers and latent tuberculosis infection in a nationally representative sample.Methods: Data from 7,042 participants in the 2011–2012 National Health and Nutrition Examination Survey and transcriptomic data from the GSE19491 dataset were analyzed. Latent tuberculosis infection was identified using the QuantiFERON-TB Gold assay. Hematological parameters were measured via complete blood counts, and inflammatory markers were calculated through these parameters. Statistical analyses included linear regression adjusted for confounders and subgroup analyses. Transcriptomic analyses involved immune cell profiling, gene set enrichment, and immune checkpoint gene expression.Results: Individuals with latent tuberculosis infection had significantly lower systemic immune-inflammation index, neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and monocyte-to-lymphocyte ratio. These associations remained significant after adjusting for age, gender, body mass index, diabetes, and hypertension. Transcriptomic analyses revealed heightened activation of memory CD4 and CD8 T cells, increased cytolytic activity, and upregulated T-cell co-inhibition pathways, alongside differential expression of immune checkpoint genes in individuals with latent tuberculosis infection.Conclusions: A lower systemic immune-inflammation index and other related hematological inflammatory markers independently correlate with latent tuberculosis infection. These findings underscore the potential significance of hematological inflammatory markers in identifying and understanding latent tuberculosis infection. Further exploration of these markers may enhance diagnostic and therapeutic strategies of tuberculosis.
- 28 November 2024
- Published by Elsevier in Biosensors and Bioelectronics
- Vol. 271, 116993
Gold metallene-based ECL biosensor to detect miRNA-126 for coronary artery calcification diagnosis
- 28 November 2024
- Published by Elsevier in Biosensors and Bioelectronics
- Vol. 271, 116993
Gold metallene-based ECL biosensor to detect miRNA-126 for coronary artery calcification diagnosis
- Open Access
- 13 October 2023
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 14, 1276194
Research progress of single-cell sequencing in tuberculosis
Tuberculosis is a major infectious disease caused by Mycobacterium tuberculosis infection. The pathogenesis and immune mechanism of tuberculosis are not clear, and it is urgent to find new drugs, diagnosis, and treatment targets. A useful tool in the quest to reveal the enigmas related to Mycobacterium tuberculosis infection and disease is the single-cell sequencing technique. By clarifying cell heterogeneity, identifying pathogenic cell groups, and finding key gene targets, the map at the single cell level enables people to better understand the cell diversity of complex organisms and the immune state of hosts during infection. Here, we briefly reviewed the development of single-cell sequencing, and emphasized the different applications and limitations of various technologies. Single-cell sequencing has been widely used in the study of the pathogenesis and immune response of tuberculosis. We review these works summarizing the most influential findings. Combined with the multi-molecular level and multi-dimensional analysis, we aim to deeply understand the blank and potential future development of the research on Mycobacterium tuberculosis infection using single-cell sequencing technology.
- 13 October 2023
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 14, 1276194
Open AccessResearch progress of single-cell sequencing in tuberculosis
Tuberculosis is a major infectious disease caused by Mycobacterium tuberculosis infection. The pathogenesis and immune mechanism of tuberculosis are not clear, and it is urgent to find new drugs, diagnosis, and treatment targets. A useful tool in the quest to reveal the enigmas related to Mycobacterium tuberculosis infection and disease is the single-cell sequencing technique. By clarifying cell heterogeneity, identifying pathogenic cell groups, and finding key gene targets, the map at the single cell level enables people to better understand the cell diversity of complex organisms and the immune state of hosts during infection. Here, we briefly reviewed the development of single-cell sequencing, and emphasized the different applications and limitations of various technologies. Single-cell sequencing has been widely used in the study of the pathogenesis and immune response of tuberculosis. We review these works summarizing the most influential findings. Combined with the multi-molecular level and multi-dimensional analysis, we aim to deeply understand the blank and potential future development of the research on Mycobacterium tuberculosis infection using single-cell sequencing technology.
- 3 September 2023
- Published by Elsevier in Biosensors and Bioelectronics
- Vol. 240, 115663
ECL resonance energy transfer-regulated “off-on” mode biosensor for the detection of miRNA-150-5p in triple negative breast cancer
- 3 September 2023
- Published by Elsevier in Biosensors and Bioelectronics
- Vol. 240, 115663
ECL resonance energy transfer-regulated “off-on” mode biosensor for the detection of miRNA-150-5p in triple negative breast cancer
- Open Access
- 13 January 2023
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 13, 1068449
Protein post-translational modification in SARS-CoV-2 and host interaction
SARS-CoV-2 can cause lung diseases, such as pneumonia and acute respiratory distress syndrome, and multi-system dysfunction. Post-translational modifications (PTMs) related to SARS-CoV-2 are conservative and pathogenic, and the common PTMs are glycosylation, phosphorylation, and acylation. The glycosylation of SARS-CoV-2 mainly occurs on spike (S) protein, which mediates the entry of the virus into cells through interaction with angiotensin-converting enzyme 2. SARS-CoV-2 utilizes glycans to cover its epitopes and evade the immune response through glycosylation of S protein. Phosphorylation of SARS-CoV-2 nucleocapsid (N) protein improves its selective binding to viral RNA and promotes viral replication and transcription, thereby increasing the load of the virus in the host. Succinylated N and membrane(M) proteins of SARS-CoV-2 synergistically affect virus particle assembly. N protein regulates its affinity for other proteins and the viral genome through acetylation. The acetylated envelope (E) protein of SARS-CoV-2 interacts with bromodomain-containing protein 2/4 to influence the host immune response. Both palmitoylation and myristoylation sites on S protein can affect the virus infectivity. Papain-like protease is a domain of NSP3 that dysregulates host inflammation by deubiquitination and impinges host IFN-I antiviral immune responses by deISGylation. Ubiquitination of ORF7a inhibits host IFN-α signaling by blocking STAT2 phosphorylation. The methylation of N protein can inhibit the formation of host stress granules and promote the binding of N protein to viral RNA, thereby promoting the production of virus particles. NSP3 macrodomain can reverse the ADP-ribosylation of host proteins, and inhibit the cascade immune response with IFN as the core, thereby promoting the intracellular replication of SARS-CoV-2. On the whole, PTMs have fundamental roles in virus entry, replication, particle assembly, and host immune response. Mutations in various SARS-CoV-2 variants, which lead to changes in PTMs at corresponding sites, cause different biological effects. In this paper, we mainly reviewed the effects of PTMs on SARS-CoV-2 and host cells, whose application is to inform the strategies for inhibiting viral infection and facilitating antiviral treatment and vaccine development for COVID-19.
- 13 January 2023
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 13, 1068449
Open AccessProtein post-translational modification in SARS-CoV-2 and host interaction
SARS-CoV-2 can cause lung diseases, such as pneumonia and acute respiratory distress syndrome, and multi-system dysfunction. Post-translational modifications (PTMs) related to SARS-CoV-2 are conservative and pathogenic, and the common PTMs are glycosylation, phosphorylation, and acylation. The glycosylation of SARS-CoV-2 mainly occurs on spike (S) protein, which mediates the entry of the virus into cells through interaction with angiotensin-converting enzyme 2. SARS-CoV-2 utilizes glycans to cover its epitopes and evade the immune response through glycosylation of S protein. Phosphorylation of SARS-CoV-2 nucleocapsid (N) protein improves its selective binding to viral RNA and promotes viral replication and transcription, thereby increasing the load of the virus in the host. Succinylated N and membrane(M) proteins of SARS-CoV-2 synergistically affect virus particle assembly. N protein regulates its affinity for other proteins and the viral genome through acetylation. The acetylated envelope (E) protein of SARS-CoV-2 interacts with bromodomain-containing protein 2/4 to influence the host immune response. Both palmitoylation and myristoylation sites on S protein can affect the virus infectivity. Papain-like protease is a domain of NSP3 that dysregulates host inflammation by deubiquitination and impinges host IFN-I antiviral immune responses by deISGylation. Ubiquitination of ORF7a inhibits host IFN-α signaling by blocking STAT2 phosphorylation. The methylation of N protein can inhibit the formation of host stress granules and promote the binding of N protein to viral RNA, thereby promoting the production of virus particles. NSP3 macrodomain can reverse the ADP-ribosylation of host proteins, and inhibit the cascade immune response with IFN as the core, thereby promoting the intracellular replication of SARS-CoV-2. On the whole, PTMs have fundamental roles in virus entry, replication, particle assembly, and host immune response. Mutations in various SARS-CoV-2 variants, which lead to changes in PTMs at corresponding sites, cause different biological effects. In this paper, we mainly reviewed the effects of PTMs on SARS-CoV-2 and host cells, whose application is to inform the strategies for inhibiting viral infection and facilitating antiviral treatment and vaccine development for COVID-19.
- Open Access
- 20 September 2022
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 13
Proteomic insights into SARS-CoV-2 infection mechanisms, diagnosis, therapies and prognostic monitoring methods
At the end of 2019, the COVID-19 pandemic, caused by severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) infection, seriously damaged world public health security. Several protein markers associated with virus infection have been extensively explored to combat the ever-increasing challenge posed by SARS-CoV-2. The proteomics of COVID-19 deepened our understanding of viral particles and their mechanisms of host invasion, providing us with information on protein changes in host tissues, cells and body fluids following infection in COVID-19 patients. In this review, we summarize the proteomic studies of SARS-CoV-2 infection and review the current understanding of COVID-19 in terms of the quantitative and qualitative proteomics of viral particles and host entry factors from the perspective of protein pathological changes in the organism following host infection.
- 20 September 2022
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 13
Open AccessProteomic insights into SARS-CoV-2 infection mechanisms, diagnosis, therapies and prognostic monitoring methods
At the end of 2019, the COVID-19 pandemic, caused by severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) infection, seriously damaged world public health security. Several protein markers associated with virus infection have been extensively explored to combat the ever-increasing challenge posed by SARS-CoV-2. The proteomics of COVID-19 deepened our understanding of viral particles and their mechanisms of host invasion, providing us with information on protein changes in host tissues, cells and body fluids following infection in COVID-19 patients. In this review, we summarize the proteomic studies of SARS-CoV-2 infection and review the current understanding of COVID-19 in terms of the quantitative and qualitative proteomics of viral particles and host entry factors from the perspective of protein pathological changes in the organism following host infection.